All research in Pharmaceutical Distribution — 1 reports.
Henry Schein is a dental and medical consumables distribution platform with added specialty products and technology services. The core thesis is that the business is understandable and cash-generative, while its moat is moderate, GAAP operating margin is only about 5%, and the current price of $76.58 offers no obvious margin of safety. Rating Watch: a credible business that should be tracked, with a better entry point or clearer evidence of margin improvement needed before a conservative long-term investor should act.
